Federal authorities are accusing two top officials of CANARX, a Canadian company, of running a long-running scheme to illegally import prescription drugs into the U.S., according to court records filed Tuesday.

John Thomas Howard, the company's treasurer and a director, was arrested Sunday on smuggling and conspiracy charges, according to the records. The arrest warrant also charges him with introducing misbranded drugs into interstate commerce and illegal drug importation. No plea has been filed.

Bob Howard, John Thomas Howard's brother and CANARX's president and a director, is also wanted in the federal investigation. He has not yet been taken into custody, according to an affidavit from Dustin Dobbs, a Food and Drug Administration special agent.

The affidavit states that the FDA found "probable cause to believe that (CANARX) illegally imported or caused the illegal importation of prescription drugs into the United States." It does not specify which medications were involved. The complaint covers February 22, 2017, through April 15, 2026.

CANARX general counsel Joseph Morris said in a statement to CNBC: "The Howards deny all the charges against them, will defend vigorously, and expect to be vindicated in court."

The FDA previously seized medication CANARX was shipping in 2023 and sent the company a warning letter in 2019. Separately, Gilead Sciences has a pending civil lawsuit accusing CANARX and other companies of illegally importing Biktarvy, its HIV medication. CANARX has not responded to that lawsuit.